UPDATE 1-Boston Scientific to buy Penumbra in $14.5 billion deal
بوسطن ساينتيفيك كورب
شركة بينومبرا
Boston Scientific Corporation BSX | 0.00 | |
Penumbra, Inc. PEN | 0.00 |
Adds details throughout
Jan 15 (Reuters) - Boston Scientific BSX.N said on Thursday it will buy Penumbra PEN.N in a deal valued at about $14.5 billion to expand its vascular pipeline.
The deal values Penumbra at $374 per share, a premium of about 19.3% to its last close. Penumbra's shares rose over 10% in premarket trading, while Boston's shares fell 4%.
The transaction is expected to be completed in 2026.
(Reporting by Mariam Sunny in Bengaluru; Editing by Shreya Biswas)
((Mariam.ESunny@thomsonreuters.com;))